Back to search

Article

Expression and pharmacological inhibition of TrkB and EGFR in glioblastoma

2020-02-04

Abstract excerpt

<h4>Background</h4> A member of the Trk family of neurotrophin receptors, tropomyosin receptor kinase B (TrkB, encoded by the NTRK2 gene) is an increasingly important target in various cancer types, including glioblastoma (GBM). EGFR is among the most frequently altered oncogenes in GBM, and EGFR inhibition has been tested as an experimental therapy. Functional interactions between EGFR and TrkB have been demon...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2f9bdef6-f38b-5306-9580-7886f621ac86
DOI
10.1101/2020.02.03.932608
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Expression and pharmacological inhibition of TrkB and EGFR in glioblastomaDOI 10.1101/2020.02.03.932608
Select a neighboring publication to make it the new centre.